Your browser version may not work well with NCBI's Web applications. More information here...
1: Mayo Clin Proc. 2007 Jun;82(6):771-3.Click here to read Links

Temozolomide-associated organizing pneumonitis.

Maldonado F, Limper AH, Lim KG, Aubrey MC.

Division of Pulmonary and Critical Care Medicine, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. maldonado.fabien@mayo.edu

Temozolomide is an oral alkylating agent recently approved for the treatment of glioblastoma multiforme. It has a favorable side effect profile and is generally well tolerated. Although mild respiratory symptoms have been described, pulmonary toxicity that requires discontinuation of therapy is rare. To our knowledge, this is the first case of temozolomide-associated organizing pneumonitis.

PMID: 17550757 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Dacarbazine (DTIC-Dome® )

    Your doctor has ordered the drug dacarbazine to help treat your illness. The drug is given by injection into a vein.

  • Temozolomide (Temodar® )

    Your doctor has ordered the drug temozolomide to help treat your illness. This medication is used to treat brain tumors (astrocytoma). The drug is taken by mouth in capsule form. Your full dose may contain two or more di...

  • Source: AHFS Consumer Medication Information